For decades, scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years ...

A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.

Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, researchers have now identified a perineural pathway through which the HIV virus ...

Left: Structure of the Human Immunodeficiency Virus (HIV). Note the envelope protein that protects the virus against immunological detection and the small genome consisting of two short strands of RNA ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

Brown researchers will look into how a drug originally developed to treat HIV may reduce age-related inflammation.

Dr. Paula Cannon is pursuing one of medicine’s most difficult goals: a cure for HIV.

Viruses need host cells, and viral pathogens have many different ways to infect those hosts. Scientists have revealed a rapid movement made by a small molecule called a glycoprotein on the surface of ...

HIV virus is one of the most pressing health concerns facing the modern world. Since the first reported case of HIV/AIDS in 1981, over 25 million people have died. Out of the millions of people ...

HIV spreads through direct contact with the bodily fluids of infected individuals. Once individuals are infected, HIV particles target our T cells, a type of white blood cell. Healthy T cells identify ...